Combined blood markers correctly detect early pancreatic cancer in human cancer cells
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every year. The blood biomarkers, detailed today in Science Translational Medicine, correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.
The majority of pancreatic cancer patients are not diagnosed until an advanced stage, beyond the point at which their tumors can be surgically removed.
A team led by Ken Zaret, PhD, director of the Penn Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology, and Gloria Petersen, PhD, from the Mayo Clinic, identified a pair of biomarkers that physicians could soon use to discover the disease earlier.
“Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,” Zaret said. The authors anticipate that health care providers will use the early-detection biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals with a high risk of developing pancreatic cancer, including those who have a first-degree relative with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.
“Early detection of cancer has had a critical influence on lessening the impact of many types of cancer, including breast, colon, and cervical cancer. A long standing concern has been that patients with pancreatic cancer are often not diagnosed until it is too late for the best chance at effective treatment,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center (ACC) at the University of Pennsylvania. “Having a biomarker test for this disease could dramatically alter the outlook for these patients.”
Novel method for discovering pancreatic cancer biomarkers
Credit: The lab of Ken Zaret, Perelman School of Medicine, University of Pennsylvania
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret’s lab, builds on a first-of-its-kind human-cell model of pancreatic cancer progression the lab described in 2013. They used stem-cell technology to create a cell line from a patient with advanced pancreatic ductal adenocarcinoma. Genetically reprogramming late-stage human cancer cells to a stem-cell state enabled them to force the reprogrammed cells to progress to an early cancerous state, revealing secreted blood biomarkers of early-stage disease along the way.
The best candidate biomarker, plasma thrombospondin-2 (THBS2), was screened against 746 cancer and control plasma samples using an inexpensive, commercially available protein-detection assay. The team found that blood levels of THBS2, combined with levels of a known later-stage biomarker called CA19-9, was reliable at detecting the presence of pancreatic cancer in patients.
The team refined the assay with independent investigations of plasma samples from patients with different stages of cancer, from individuals with benign pancreatic disease, and from healthy controls, all obtained from Petersen, who directs the biospecimen resource program for pancreas research at the Mayo Clinic.
“Positive results for THBS2 or CA19-9 concentrations in the blood consistently and correctly identified all stages of the cancer,” Zaret said. “Notably, THBS2 concentrations combined with CA19-9 identified early stages better than any other known method.” The combination panel also improved the ability to distinguish cases of cancer from pancreatitis. The panel will next be validated in a set of samples from pancreatic cancer patients who provided a research blood sample prior to their diagnosis.
The Latest on: Pancreatic cancer
- US Patent Issued on CPSI’s FrostBite™ Pancreas Cancer Cryoablation Catheter on February 15, 2018 at 7:31 pm
Owego, NY, February 15, 2018 –(PR.com)– CPSI Biotech announced today the issuance of a patent (US Pat#: 9,877,767) by the US Patent Office covering a new endoscopic based ablation catheter designed for the minimally invasive treatment of pancreatic cancer. […]
- New mother, 28, crippled by stomach pains, weeks after giving birth, was diagnosed with 'the worst form of cancer' on February 14, 2018 at 2:54 am
A 28-year-old mother who endured agonising stomach pains weeks after giving birth was diagnosed with 'the worst form of cancer'. Amy Blackrock, of Kirkby, Liverpool, was told she had pancreatic cancer, which kills 90 per cent of patients within five years. […]
- Love at Center of Pancreatic Cancer Battle on February 13, 2018 at 2:49 pm
This Valentine’s Day, Bartlett residents Kathryn and Tom Craig want to share their story of love and support as encouragement to those who are battling cancer with a loved one. Kathryn is a five-year survivor of pancreatic cancer, one of the deadliest ... […]
- Time To Put The Spotlight On Pancreatic Cancer Again on February 12, 2018 at 7:29 am
Pancreatic cancer is one of the most fatal cancers in the world. In the UK, only one in 20 people diagnosed live to see another five years and one in 100 people survive beyond ten years. These figures have not changed significantly in 50 years. Being the ... […]
- Pancreatic cancer WARNING – why you should never ignore back pain on February 11, 2018 at 11:56 pm
Pancreatic cancer often doesn’t cause any symptoms in its early stages. As the disease progresses, some signs of the cancer may begin to show. While the symptoms don’t necessarily mean you have pancreatic cancer, you should see a GP if you’re worried ... […]
- Liam Miller dead aged 36: Manchester United and Celtic stars pay tribute after Irishman loses battle with pancreatic cancer on February 10, 2018 at 12:53 pm
“It is with great sadness that I learned of the death of Liam Miller, who brought skill and passion to his games, for the Republic of Ireland, Cork City, Celtic, Manchester Utd. and other clubs. I send my condolences to his family and friends, and all ... […]
- Scans could help tailor pancreatic cancer treatment on February 9, 2018 at 9:24 am
Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to the National Institute for Health and Care Excellence (NICE). New guidance from NICE says a PET-CT scan should be used ... […]
- Liverpool pancreatic cancer research gets £1.5m boost on February 9, 2018 at 3:33 am
University of Liverpool scientists have been given £1.5m to research treatments for pancreatic cancer patients. They will analyse samples from patients at Royal Liverpool University Hospital and Aintree University Hospital to investigate how the cancer ... […]
- Former Waco nurse defying odds after pancreatic cancer diagnosis on February 6, 2018 at 3:52 pm
Marliss Williams doesn’t like the phrase “fighting cancer” any more than she likes watching boxing or wrestling on TV. She almost always turns off the TV or goes in another room, and she is quick to say the last four years of her life have been about ... […]
- COMPASS: Genomic Profiling Could Guide Treatment in Advanced Pancreatic Cancer on February 2, 2018 at 2:12 pm
As part of our coverage of the 2018 Gastrointestinal Cancers Symposium, held January 18–20 in San Francisco, we are speaking with Kyaw L. Aung, MBBS, PhD, a clinical fellow at the Princess Margaret Cancer Centre in Toronto. Dr. Aung presented updated ... […]
via Google News and Bing News